81 related articles for article (PubMed ID: 7879247)
21. Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation.
Hopt UT; Pfeffer F; Schareck W; Büsing M; Ming C
Transplant Proc; 1994 Apr; 26(2):434-5. PubMed ID: 8171489
[No Abstract] [Full Text] [Related]
22. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
[TBL] [Abstract][Full Text] [Related]
23. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
Hakkert A; Dykeman-Sharpe J
CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
[No Abstract] [Full Text] [Related]
24. Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation.
Mañez R; Breinig MK; Kusne S; Linden P; Kramer D; Armstrong J; Ho M
Transplantation; 1995 Apr; 59(8):1220-3. PubMed ID: 7537400
[No Abstract] [Full Text] [Related]
25. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
O'Hair DP; Johnson CP; Roza AM; Adams MB
Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
[No Abstract] [Full Text] [Related]
26. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
[No Abstract] [Full Text] [Related]
28. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
Prian GW; Koep LJ
Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977
[No Abstract] [Full Text] [Related]
29. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.
Werner BG; Snydman DR; Freeman R; Rohrer R; Tilney NL; Kirkman RL
Transplant Proc; 1993 Feb; 25(1 Pt 2):1441-3. PubMed ID: 8382875
[No Abstract] [Full Text] [Related]
30. Cytomegalovirus prophylaxis in antibody-treated renal transplanted patients.
Birkeland S; Gahrn-Hansen B; Andersen H; Rohr N; Larsen KE; Jørgensen A
Transplant Proc; 1995 Dec; 27(6):3473-6. PubMed ID: 8540056
[No Abstract] [Full Text] [Related]
31. Cytomegalovirus infection and prophylaxis in heart transplantation.
Laske A; Gallino A; Carrel T; Niederhäuser U; von Segesser LK; Turina MI
Transplant Proc; 1993 Feb; 25(1 Pt 2):1427-8. PubMed ID: 8382870
[No Abstract] [Full Text] [Related]
32. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
33. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
[TBL] [Abstract][Full Text] [Related]
34. Optimization of cyclosporine monotherapy--long-term graft function.
Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
[No Abstract] [Full Text] [Related]
35. CMV infection after kidney transplantation in children.
Lehnert A; Niaudet P; Broyer M
Transplant Proc; 1996 Oct; 28(5):2805. PubMed ID: 8908068
[No Abstract] [Full Text] [Related]
36. Extended ganciclovir prophylaxis in lung transplantation.
Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis of cytomegalovirus disease in allogeneic bone marrow transplantation.
Grigg A; Phillips G
J Infect Dis; 1992 May; 165(5):972-3. PubMed ID: 1314874
[No Abstract] [Full Text] [Related]
38. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
39. Three cases of cytomegalovirus infection following pancreatic islet transplantation.
Yakubovich N; Fung MA; Thompson DM
Transplant Proc; 2007 Jun; 39(5):1599-603. PubMed ID: 17580197
[TBL] [Abstract][Full Text] [Related]
40. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
